ArticleCancer research2026

Prolonged KRAS-MAPK Inhibition Induces Interferon Signaling That Promotes Cell State Transition and Confers Therapeutic Vulnerabilities.

Ashenafi Bulle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.